Free Trial
NASDAQ:HSTO

Histogen (HSTO) Stock Price, News & Analysis

Histogen logo
$0.0012 +0.00 (+9.09%)
As of 06/5/2025

About Histogen Stock (NASDAQ:HSTO)

Key Stats

Today's Range
$0.0012
$0.0012
50-Day Range
$0.00
$0.03
52-Week Range
$0.05
$0.55
Volume
517 shs
Average Volume
10,369 shs
Market Capitalization
$5.12 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Histogen Inc., a clinical-stage therapeutics company, focuses on developing clinical and preclinical small molecule pan-caspase and caspase selective inhibitors that protect the body's natural process to restore immune function. The company's product candidates include emricasan for the treatment of acute bacterial skin and skin structure infections, as well as other infectious diseases. Its preclinical product candidates include CTS-2090 and CTS-2096, which are selective small molecule inhibitors of caspase-1 designed for the treatment of various inflammatory diseases. Histogen Inc. was founded in 2007 and is based in San Diego, California. On April 18, 2024, Histogen Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of California.

Receive HSTO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Histogen and its competitors with MarketBeat's FREE daily newsletter.

HSTO Stock News Headlines

"I'm risking my reputation on this"
Behind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the same signals. They're positioning themselves for something unprecedented. And after 17 million podcast downloads and over 600 insider interviews, I finally connected all the dots… What I discovered was so explosive, so potentially life-changing, that I had to put it all in a book.
Histogen Files For Voluntary Chapter 11 Bankruptcy Protection
See More Headlines

HSTO Stock Analysis - Frequently Asked Questions

Histogen's stock was trading at $0.0250 at the start of the year. Since then, HSTO shares have decreased by 95.2% and is now trading at $0.0012.
View the best growth stocks for 2025 here
.

Histogen Inc. (NASDAQ:HSTO) announced its quarterly earnings data on Wednesday, November, 10th. The company reported ($1.80) earnings per share for the quarter, beating the consensus estimate of ($2.20) by $0.40. The business earned $0.59 million during the quarter.

Shares of Histogen reverse split before market open on Friday, June 3rd 2022. The 1-20 reverse split was announced on Friday, June 3rd 2022. The number of shares owned by shareholders was adjusted after the market closes on Friday, June 3rd 2022. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Shares of HSTO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Histogen investors own include Tesla (TSLA), Bionano Genomics (BNGO), Applied Genetic Technologies (AGTC), HubSpot (HUBS), Meta Platforms (META) and TherapeuticsMD (TXMD).

Company Calendar

Last Earnings
11/10/2021
Today
6/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:HSTO
Fax
N/A
Employees
20
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$19 thousand
Price / Cash Flow
N/A
Book Value
$3.13 per share
Price / Book
0.00

Miscellaneous

Free Float
N/A
Market Cap
$5.12 thousand
Optionable
Not Optionable
Beta
1.19
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NASDAQ:HSTO) was last updated on 6/7/2025 by MarketBeat.com Staff
From Our Partners